Lonza, ALSA Ventures collaborate on providing manufacturing services to biotech firms
The new framework collaboration will support due diligence into ALSA’s potential investments, which will assist with their investment de-risking
The new framework collaboration will support due diligence into ALSA’s potential investments, which will assist with their investment de-risking
Glenmark's current portfolio consists of 174 products authorized for distribution in the U.S. marketplace and 48 ANDA's pending approval with the USFDA
The plan is to advance innovative therapies to drug-resistant cancers
Lupin recognized the need to digitize more applications, improve scalability, decrease risk of security breaches and eliminate critical data loss
The workshop was organized by the Department of Urology as a first step to enabling government medical colleges in Rajasthan to offer the latest surgical technology
This partnership expands DNA Script’s footprint and provides sales and support for the SYNTAX System DNA printer in labs in India
Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
Funds will be allocated to accelerate rapid production and high-end curation of whole genome sequences for its clinical application
Move brings together AstraZeneca and Alexion colleagues in a purpose-built facility in Kendall Square, Cambridge, MA, a world-leading life sciences hub
To extend the nationwide distribution network for the availability of its proprietary & award-winning HPod for corporates & doctors’ clinics, thereby strengthening India’s phygital wellness ecosystem
Subscribe To Our Newsletter & Stay Updated